Showing results (141-150 of 226) with videos related to

Sort By:
Pageof 23
Annals of Intensive Care|August 25, 2016
Teamwork enables high level of early mobilization in critically ill patientsCheryl Elizabeth Hickmann, Diego Castanares-Zapatero, Emilie Bialais, et al.
Minerva Anestesiologica|March 10, 2016
Closed-loop ventilation mode (IntelliVent®-ASV) in intensive care unit: a randomized trialEmilie Bialais, Xavier Wittebole, Laurence Vignaux, et al.
Critical Care Medicine|August 8, 2009
Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsisMark Tidswell, William Tillis, Steven P Larosa, et al.
Infection and Immunity|July 26, 2005
Inter-alpha-inhibitor proteins are endogenous furin inhibitors and provide protection against experimental anthrax intoxicationSteven M Opal, Andrew W Artenstein, Patricia A Cristofaro, et al.
Critical Care (London, England)|March 17, 2009
A clinical evaluation committee assessment of recombinant human tissue factor pathway inhibitor (tifacogin) in patients with severe community-acquired pneumoniaPierre-François Laterre, Steven M Opal, Edward Abraham, et al.
Intensive Care Medicine|February 17, 2018
Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP)Jean-Louis Vincent, Jean-Yves Lefrant, Katarzyna Kotfis, et al.
British Journal of Clinical Pharmacology|January 22, 2025
Variable temocillin protein binding and pharmacokinetics in different clinical conditions: Implications for target attainmentLetao Li, Perrin Ngougni Pokem, Sebastiaan D T Sassen, et al.
Antimicrobial Agents and Chemotherapy|December 17, 2014
The novel immunotherapeutic oligodeoxynucleotide IMT504 protects neutropenic animals from fatal Pseudomonas aeruginosa bacteremia and sepsisAbdullah Chahin, Steven M Opal, Jorge Zorzopulos, et al.
Shock (Augusta, Ga.)|June 5, 2010
Inter-α inhibitor proteins: a novel therapeutic strategy for experimental anthrax infectionSteven M Opal, Yow-Pin Lim, Patricia Cristofaro, et al.
Vaccine|October 25, 2003
Phase I study of detoxified Escherichia coli J5 lipopolysaccharide (J5dLPS)/group B meningococcal outer membrane protein (OMP) complex vaccine in human subjectsAlan S Cross, Steven M Opal, John E Palardy, et al.
Pageof 23